H J Senn
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
Burstein H, Gnant M, Winer E, Senn H, Regan M, Poortmans P, Weber W, Thürlimann B, Curigliano G, Panelists of the St Gallen Consensus Conference. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol 2021; 32:1216-1235.
06.07.2021Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
06.07.2021Ann Oncol 2021; 32:1216-1235
Burstein H J, Gnant M, Winer E P, Senn H J, Regan M M, Poortmans P, Weber W P, Thürlimann Beat, Curigliano G, Panelists of the St Gallen Consensus Conference
St. Gallen 2009 recommendations on the treatment of early breast cancer: consensus and controversy
Jörger M, Senn H, Thürlimann B. St. Gallen 2009 recommendations on the treatment of early breast cancer: consensus and controversy. magazine of european medical oncology 2009; 2:229-231.
01.01.2009St. Gallen 2009 recommendations on the treatment of early breast cancer: consensus and controversy
01.01.2009magazine of european medical oncology 2009; 2:229-231
Jörger Markus, Senn H J, Thürlimann Beat
Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
Glaus A, Böhme C, Thürlimann B, Ruhstaller T, Hsu Schmitz S, Morant R, Senn H, von Moos R. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 2006; 17:801-6.
01.05.2006Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
01.05.2006Ann Oncol 2006; 17:801-6
Glaus A, Böhme Christel, Thürlimann Beat, Ruhstaller Thomas, Hsu Schmitz S F, Morant R, Senn H J, von Moos R
[Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]
Thürlimann B, Senn H. [Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]. Gynäkologisch-geburtshilfliche Rundschau 2005; 45:143-6.
01.06.2005[Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]
01.06.2005Gynäkologisch-geburtshilfliche Rundschau 2005; 45:143-6
Thürlimann Beat, Senn H J
Identifying breast cancer patients at high risk for bone metastases
Colleoni M, Senn H, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Collins J, Lindtner J, O'Neill A, Goldhirsch A, Gelber R, Bonetti M, Thürlimann B, Price K, Castiglione-Gertsch M, Coates A, Rudenstam C. Identifying breast cancer patients at high risk for bone metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000; 18:3925-35.
01.12.2000Identifying breast cancer patients at high risk for bone metastases
01.12.2000Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000; 18:3925-35
Colleoni M, Senn H J, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Collins J, Lindtner J, O'Neill A, Goldhirsch A, Gelber R D, Bonetti M, Thürlimann Beat, Price K N, Castiglione-Gertsch M, Coates A S, Rudenstam C M
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
Crivellari D, Senn H, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Collins J, Lindtner J, Bernhard J, Bonetti M, Castiglione-Gertsch M, Gelber R, Rudenstam C, Thürlimann B, Price K, Coates A, Hürny C, Goldhirsch A. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000; 18:1412-22.
01.04.2000Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
01.04.2000Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000; 18:1412-22
Crivellari D, Senn H J, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Collins J, Lindtner J, Bernhard J, Bonetti M, Castiglione-Gertsch M, Gelber R D, Rudenstam C M, Thürlimann Beat, Price K N, Coates A S, Hürny C, Goldhirsch A
Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients
Sabbioni M, Goldhirsch A, Perey L, Bonnefoi H, Thürlimann B, Bernhard J, Bacchi M, Siegrist H, Hürny C, Castiglione M, Senn H. Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999; 7:149-53.
01.05.1999Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients
01.05.1999Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999; 7:149-53
Sabbioni M E, Goldhirsch A, Perey L, Bonnefoi H, Thürlimann Beat, Bernhard J, Bacchi M, Siegrist H P, Hürny C, Castiglione M, Senn H J
Pamidronate treatment in patients with malignant osteolytic bone disease and pain: a prospective randomized double-blind trial
Köberle D, Bacchus L, Thürlimann B, Senn H. Pamidronate treatment in patients with malignant osteolytic bone disease and pain: a prospective randomized double-blind trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999; 7:21-7.
01.01.1999Pamidronate treatment in patients with malignant osteolytic bone disease and pain: a prospective randomized double-blind trial
01.01.1999Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999; 7:21-7
Köberle Dieter, Bacchus L, Thürlimann Beat, Senn H J
Diagnostic and prognostic value of biochemical markers in malignant bone disease: a prospective study on the effect of bisphosphonate on pain intensity and progression of malignant bone disease
Engler H, Köberle D, Thürlimann B, Senn H, Riesen W. Diagnostic and prognostic value of biochemical markers in malignant bone disease: a prospective study on the effect of bisphosphonate on pain intensity and progression of malignant bone disease. Clinical chemistry and laboratory medicine : CCLM / FESCC 1998; 36:879-85.
01.11.1998Diagnostic and prognostic value of biochemical markers in malignant bone disease: a prospective study on the effect of bisphosphonate on pain intensity and progression of malignant bone disease
01.11.1998Clinical chemistry and laboratory medicine : CCLM / FESCC 1998; 36:879-85
Engler H, Köberle Dieter, Thürlimann Beat, Senn H J, Riesen W F
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)
Bernhard J, Senn H, Goldhirsch A, Forbes J, Thürlimann B, Marini G, Galligioni E, Gelber R, Castiglione-Gertsch M, Peterson H, Coates A, Hürny C, Rudenstam C. Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG). British journal of cancer 1998; 78:686-93.
01.09.1998Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG)
01.09.1998British journal of cancer 1998; 78:686-93
Bernhard J, Senn H J, Goldhirsch A, Forbes J F, Thürlimann Beat, Marini G, Galligioni E, Gelber R D, Castiglione-Gertsch M, Peterson H F, Coates A S, Hürny C, Rudenstam C M
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI
Pagani O, Price K, Fey M, Simoncini E, Thürlimann B, Cavalli F, Coates A, Crivellari D, Collins J, Lindtner J, Rudenstam C, Goldhirsch A, Gelber R, Castiglione M, O'Neill A, Senn H. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. European journal of cancer (Oxford, England : 1990) 1998; 34:632-40.
01.04.1998Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI
01.04.1998European journal of cancer (Oxford, England : 1990) 1998; 34:632-40
Pagani O, Price K, Fey M, Simoncini E, Thürlimann Beat, Cavalli F, Coates A, Crivellari D, Collins J, Lindtner J, Rudenstam C M, Goldhirsch A, Gelber R D, Castiglione M, O'Neill A, Senn H J
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
Goldhirsch A, Price K, Pagani O, Fey M, Simoncini E, Cavalli F, Coates A, Crivellari D, Forbes J, Collins J, Lindtner J, Rudenstam C, Thürlimann B, O'Neill A, Castiglione M, Gelber R, Senn H. Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997; 8:751-6.
01.08.1997Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
01.08.1997Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997; 8:751-6
Goldhirsch A, Price K, Pagani O, Fey M F, Simoncini E, Cavalli F, Coates A, Crivellari D, Forbes J, Collins J, Lindtner J, Rudenstam C M, Thürlimann Beat, O'Neill A, Castiglione M, Gelber R D, Senn H J
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
Thürlimann B, Fey M, Senn H, Cavalli F, Jungi W, Goldhirsch A, Castiglione-Gertsch M, Bacchi M, Beretta K, Löhnert T. First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996; 7:471-9.
01.07.1996First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
01.07.1996Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996; 7:471-9
Thürlimann Beat, Fey M, Senn H J, Cavalli F, Jungi W F, Goldhirsch A, Castiglione-Gertsch M, Bacchi M, Beretta K, Löhnert T
The changing approach to the treatment of early breast cancer
Thürlimann B, Senn H. The changing approach to the treatment of early breast cancer. The New England journal of medicine 1996; 334:1397-9.
23.05.1996The changing approach to the treatment of early breast cancer
23.05.1996The New England journal of medicine 1996; 334:1397-9
Thürlimann Beat, Senn H J
Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial
Thürlimann B, Waldburger R, Senn H, Thiébaud D. Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial. Ann Oncol 1992; 3:619-23.
01.09.1992Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial
01.09.1992Ann Oncol 1992; 3:619-23
Thürlimann Beat, Waldburger R, Senn H J, Thiébaud D
[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
Morant R, Thürlimann B, Jungi W, Schmid L, Holdener E, Schmid U, Senn H. [Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]. Schweiz Med Wochenschr 1991; 121:344-6.
09.03.1991[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
09.03.1991Schweiz Med Wochenschr 1991; 121:344-6
Morant R, Thürlimann Beat, Jungi W F, Schmid L, Holdener E, Schmid U, Senn H J
Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer
Schmid L, Thürlimann B, Müller M, Senn H. Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer. Recent Results Cancer Res 1991; 121:173-81.
01.01.1991Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer
01.01.1991Recent Results Cancer Res 1991; 121:173-81
Schmid L, Thürlimann Beat, Müller M, Senn H J
Anthracycline-carboplatin combination in metastatic breast cancer
Thürlimann B, Senn H, Jungi W. Anthracycline-carboplatin combination in metastatic breast cancer. J Cancer Res Clin Oncol 1990; 116:13-4.
01.01.1990Anthracycline-carboplatin combination in metastatic breast cancer
01.01.1990J Cancer Res Clin Oncol 1990; 116:13-4
Thürlimann Beat, Senn H J, Jungi W F
[Safety problems in the handling of cytostatics]
Thürlimann B, Senn H. [Safety problems in the handling of cytostatics]. Ther Umsch 1988; 45:403-7.
01.06.1988[Safety problems in the handling of cytostatics]
01.06.1988Ther Umsch 1988; 45:403-7
Thürlimann Beat, Senn H J
[Secondary malignancies after breast cancer surgery. Comparison of retro- and prospective findings]
Holdener E, Osterwalder J, Senn H, Enderlin F, Gloor F. [Secondary malignancies after breast cancer surgery. Comparison of retro- and prospective findings]. Schweiz Med Wochenschr 1982; 112:1800-4.
04.12.1982[Secondary malignancies after breast cancer surgery. Comparison of retro- and prospective findings]
04.12.1982Schweiz Med Wochenschr 1982; 112:1800-4
Holdener E E, Osterwalder Joseph, Senn H J, Enderlin F, Gloor F